INNOVISION
INNOVISION
Each stock's 10,000-path forecast, rendered as light.
INNOVISION (INNOVISION) Stock Analysis & Case Study
Is INNOVISION a good buy? The data-driven verdict.
INNOVISION (INNOVISION) trades at ₹297,on the numbers it mixed signals, a Downstox Snapshot Score of 54/100.
On the numbers, INNOVISION (INNOVISION) mixed signals, a Downstox Snapshot Score of 54/100, weighing fairly valued at 19.2× earnings, ROE of 19.6%, a 1% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
INNOVISION fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
Is INNOVISION overvalued? INNOVISION P/E vs its sector
INNOVISION's P/E of 19.2× sits above the sector peer median of 15.9×, so on earnings it screens richer than peers.
INNOVISION share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 0.2y of INNOVISION history (-97%/yr drift, 42%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| INNOVISION 2027 | ₹59 | ₹102 | ₹178 | -65% |
| INNOVISION 2028 | ₹16 | ₹35 | ₹78 | -88% |
| INNOVISION 2029 | ₹5 | ₹12 | ₹32 | -96% |
| INNOVISION 2030 | ₹1 | ₹4 | ₹13 | -99% |
| INNOVISION 2031 | ₹0 | ₹1 | ₹5 | -100% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability INNOVISION goes up, or doubles?
The bull case for INNOVISION
- A 19.2× P/E sits in the fair-value band, neither cheap nor stretched.
- High return on equity (19.6%), the business compounds shareholder capital efficiently, the hallmark of a quality franchise.
- Strong ROCE (20.3%) shows the core business earns well above its cost of capital.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹32.
The bear case & risks
- A low Piotroski F-Score of 3/9 flags weaker financial health this cycle, worth understanding why before committing.
- The probability model is cautious 12 months out, only a 1% chance of finishing above today's price.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹5.
INNOVISION volatility & expected range, how bumpy is the ride?
Over the last 0.2 years INNOVISION compounded at -97%/year with annualized volatility of 42%. That volatility implies a 1-year 80% range of ₹59–₹178, the honest backbone behind any single price target.
INNOVISION price forecast, the full 60-month probability fan
INNOVISION price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds INNOVISION hits common targets within the simulated horizon?
Full multi-horizon detail on the INNOVISION price target & forecast page.
INNOVISION Piotroski F-Score: 3/9, how financially strong is it?
The Piotroski F-Score grades financial strength on nine profitability, leverage and efficiency checks. INNOVISION scores 3/9,weak on the financial-strength checks.
INNOVISION MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy INNOVISION with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| ZerodhaCHEAPEST | 50.0% | 2.0× |
Compare every broker on the INNOVISION MTF page.
INNOVISION vs peers,sector comparison
About INNOVISION: sector, index & market-cap context
INNOVISION (INNOVISION) is a small-cap NSE-listed company, and a constituent of the Nifty 500 index group, with a market capitalisation of ₹708 Cr. See more Nifty 500 stocks.
How the INNOVISION Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of INNOVISION's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
INNOVISION analysis, FAQs
Is INNOVISION (INNOVISION) a good buy?
On the numbers, INNOVISION (INNOVISION) mixed signals, a Downstox Snapshot Score of 54/100, weighing fairly valued at 19.2× earnings, ROE of 19.6%, a 1% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is INNOVISION overvalued or undervalued?
INNOVISION trades at 19.2× earnings versus a peer median of 15.9×, so it screens richer than its sector peers.
What is the INNOVISION share price target for 2031?
INNOVISION's probability-weighted 2031 median target is ₹1, with an 80% range of ₹0–₹5 (10,000-path Monte-Carlo).
What is the probability INNOVISION doubles in 5 years?
The modelled probability of INNOVISION reaching ₹594 (2×) within 5 years is 0%.
What is the bull case for INNOVISION?
A 19.2× P/E sits in the fair-value band, neither cheap nor stretched. High return on equity (19.6%), the business compounds shareholder capital efficiently, the hallmark of a quality franchise. Strong ROCE (20.3%) shows the core business earns well above its cost of capital.
What are the risks in INNOVISION?
A low Piotroski F-Score of 3/9 flags weaker financial health this cycle, worth understanding why before committing. The probability model is cautious 12 months out, only a 1% chance of finishing above today's price.